Dupilumab had a fivefold improvement in sustained disease remission in bullous pemphigoid compared with placebo, along with a significant reduction in oral corticosteroid use.

But Black or African American subgroups (approximately 15% of each group) saw a more pronounced protective effect with dupilumab for anxiety (HR = 0.414; 95% CI, 0.268-0.641), depressive disorders ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

About 68 per cent of patients on Dupixent experienced side effects, which was consistent ... has approved Dupixent (dupilumab) injections as an add-on therapy for adults with chronic obstructive ...

Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to a press release from the ...

1 Dupilumab is being jointly developed by Regeneron ... Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side ...

‘Dupilumab reduced symptoms by a magnitude ... She has also been left with long-term side-effects from a steroid- based inhaler. After trying five different drugs, she says: ‘I’m looking ...